sonrotoclax · Beone Medicines Usa · NDA 220711
Beqalzi
Earliest generic entry, as listed · earliest of 4 marketed strengths
29 Apr 2039
Blocked by patent: US 11420968.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11420968 | drug substance, drug product · sets the listed date | 29 Apr 2039 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 13 May 2031 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220711 · 001 · RLD | tablet, oral | 1MG | 29 Apr 2039 |
| 220711 · 002 · RLD | tablet, oral | 5MG | 29 Apr 2039 |
| 220711 · 003 · RLD | tablet, oral | 20MG | 29 Apr 2039 |
| 220711 · 004 · RLD | tablet, oral | 80MG | 29 Apr 2039 |